Clinical trial
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease…
NCT00212316 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00212316 |
|---|---|
| Title | Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) |
| Official title | Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease |
| Lead sponsor | University of Rochester, Other |
| Collaborators | HP Therapeutics Foundation Massachusetts General Hospital Columbia University University of Iowa University of California, San Diego University of Kansas University of Alabama at Birmingham Johns… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Huntington's Disease |
| Intervention type | Drug |
| Interventions | sodium phenylbutyrate |
| Enrollment | 60 |
| Start date | Aug 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: